Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Rhea-AI Summary

Accuray (NASDAQ: ARAY) will report third quarter fiscal 2026 results for the period ended March 31, 2026, on May 6, 2026 with a conference call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast and a one-week replay will be available via the Investor Relations website. Investor contact: Investor.relations@accuray.com.

News Market Reaction – ARAY

-3.08%

11 alerts

-3.08% Session close to close

+6.1% Peak in 6 hr 28 min

$55.47M Market Cap

0.5x Rel. Volume

In the Apr 23 session, ARAY declined 3.08%, reflecting a moderate negative market reaction. Argus tracked a peak move of +6.1% during that session. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timeline for Accuray’s Q3 FY2026 results, covering the period ended March...

Analysis

This announcement sets the timeline for Accuray’s Q3 FY2026 results, covering the period ended March 31, 2026, with a conference call on May 6, 2026. In recent quarters, ARAY has reported declining revenue and losses while pursuing a transformation plan targeting about $25M in annualized operating improvements. Investors may focus on updated revenue trends, margins, restructuring progress, and any revisions to FY2026 guidance when the company reports.

Key Figures

Q3 FY2026 period end: March 31, 2026 Earnings call date: May 6, 2026 Earnings call time PT: 1:30 p.m. PT +5 more

8 metrics

Q3 FY2026 period end March 31, 2026 Quarter for upcoming financial results

Earnings call date May 6, 2026 Scheduled Q3 FY2026 results conference call

Earnings call time PT 1:30 p.m. PT Start time for Q3 FY2026 call

Earnings call time ET 4:30 p.m. ET Start time for Q3 FY2026 call

US dial-in 1-833-316-0563 Primary U.S. conference call number

International dial-in 1-412-317-5747 International conference call number

Replay US dial-in 1-855-669-9658 U.S. replay number, available for one week

Replay conference ID 4178502 Conference ID for Q3 FY2026 call replay

Previous Earnings date Reports

1 past event · Latest: Jan 21 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 21	Earnings date notice	Neutral	+2.5%	Announcement of Q2 FY2026 earnings release date and conference call logistics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The only prior earnings date release in the last six months saw a modest positive move, suggesting that scheduling earnings calls has historically been associated with a mild upward price reaction for ARAY.

Recent Company History

Recent news shows ARAY balancing transformation efforts and weakening financial performance. Q1 FY2026 results on Nov 5, 2025 and Q2 results on Feb 4, 2026 both reported year-over-year revenue declines and losses. A transformation plan announced on Dec 15, 2025 targeted about $25M in annualized operating improvements and headcount reductions. Leadership changes, including a new CEO and a new Chief Commercial Officer, underscore a strategic reset. Today’s Q3 FY2026 earnings date notice continues the cadence of regular financial disclosures.

Key Terms

webcast, investor relations, radiation therapy, oncology, +1 more

5 terms

webcast technical

"A live webcast of the call will also be available from the Investor"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

investor relations financial

"available from the Investor Relations section of the company's website"

Investor relations is the communication process between a company and its current or potential investors. It involves sharing information about the company's performance, strategies, and outlook to help investors make informed decisions. Effective investor relations build trust and transparency, similar to a clear conversation between a business and someone considering investing, ensuring both parties understand each other's interests and expectations.

radiation therapy medical

"committed to expanding the powerful potential of radiation therapy to"

Radiation therapy uses focused high-energy rays or particles to kill or shrink abnormal cells inside the body, often delivered from outside the body or by placing tiny sources near the target. Think of it like using a magnifying glass to concentrate sunlight on a small spot to remove a weed without digging up the whole garden. Investors watch radiation therapy because its effectiveness, side effects, regulatory approvals, equipment needs and reimbursement rules directly affect healthcare companies’ revenues, clinical trial outcomes and long-term costs.

oncology medical

"innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond"

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

neuro-radiosurgery medical

"innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond"

A non‑invasive medical procedure that delivers a very precise, high dose of focused radiation to targets in the brain or spinal cord, intended to treat tumors, abnormal blood vessels, or certain functional disorders without open surgery. Investors should care because it represents a growing treatment option that can shorten hospital stays, reduce complication risks, and drive demand for specialized equipment, software and reimbursement changes—factors that affect healthcare providers’ revenues and medical device makers’ sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated

FAQ

When will Accuray (ARAY) report third quarter fiscal 2026 results?

Accuray will report third quarter fiscal 2026 results on May 6, 2026. According to Accuray, the company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and provide a webcast for investors.

How can investors join the ARAY earnings conference call on May 6, 2026?

Investors can join the conference call by dialing the provided U.S. or international numbers or via live webcast. According to Accuray, the webcast is accessible from the Investor Relations section at investors.accuray.com.

Will there be a replay of the Accuray (ARAY) May 6, 2026 earnings call?

A dial-up replay will be available for one week starting about one hour after the call concludes. According to Accuray, the replay uses conference ID 4178502 and is also available on the investor website until Q4 results are announced.

Where can I find the Accuray (ARAY) webcast and replay for the Q3 fiscal 2026 call?

The live webcast and replay are hosted on Accuray's Investor Relations website. According to Accuray, the webcast replay will remain available online until the company announces its fourth quarter fiscal 2026 results.

Who should investors contact for inquiries about Accuray (ARAY) Q3 fiscal 2026 results?

Investors and media should contact the company's investor relations email provided in the announcement. According to Accuray, inquiries can be sent to Investor.relations@accuray.com for further information and access details.